Breaking News Instant updates and real-time market news.

CSX

CSX

$46.93

0.3 (0.64%)

, ADS

Alliance Data

$254.88

14.24 (5.92%)

09:56
04/20/17
04/20
09:56
04/20/17
09:56

Early notable gainers among liquid option names on April 20th

Notable gainers among liquid option names this morning include CSX (CSX) $49.88 +2.94, Alliance Data (ADS) $255.59 +14.38, KeyCorp (KEY) $18.17 +0.80, Gap (GPS) $25.20 +0.97, and American Express (AXP) $78.34 +2.80.

CSX

CSX

$46.93

0.3 (0.64%)

ADS

Alliance Data

$254.88

14.24 (5.92%)

KEY

KeyCorp

$18.01

0.6389 (3.68%)

GPS

Gap

$25.26

1.04 (4.29%)

AXP

American Express

$78.20

2.65 (3.51%)

  • 20

    Apr

  • 20

    Apr

  • 20

    Apr

  • 01

    May

  • 08

    May

  • 17

    May

CSX CSX
$46.93

0.3 (0.64%)

03/15/17
WOLF
03/15/17
NO CHANGE
WOLF
Wolfe cuts Railroads to Market Weight, downgrades Norfolk Southern
Wolfe Research analyst Scott Group downgraded the Railroad sector to Market Weight from Overweight saying the risk/reward profiles are more balanced following the recent expansion of valuations. Group coupled the sector cut with a downgrade of Norfolk Southern (NSC) to Peer Perform from Outperform. The analyst thinks the company's operating ratio improvement could disappoint relative to CSX (CSX). He believes CSX has the best earnings story in the space under CEO Hunter Harrison.
03/15/17
ATLE
03/15/17
UPGRADE
Target $57
ATLE
Overweight
CSX upgraded to Overweight from Neutral at Atlantic Equities
Atlantic Equities analyst Lindsay Bettiol upgraded CSX to Overweight with an increased price target of $57.
03/15/17
03/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Hold from Underperform at Jefferies with analyst John Janedis saying he believes Netflix's international growth opportunity is larger than he had expected. The company's original content is performing well, mobile consumption is growing and competition appears limited, Janedis tells investors in a research note. 2. CSX (CSX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Amec Foster Wheeler (AMFW) was upgraded to Neutral from Underperform at Exane BNP Paribas and to Outperform from Market Perform at Raymond James. 4. Harley-Davidson (HOG) upgraded to Neutral from Underperform at Longbow. 5. Finisar (FNSR) upgraded to Buy from Hold at Jefferies with analyst James Kisner saying the current valuation discounts no recovery in China and no resolution of recent technical issues. The analyst views the company's issues as temporary and upped his price target for the shares to $34 from $32. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/24/17
LEHM
03/24/17
NO CHANGE
Target $55
LEHM
Overweight
CSX price target raised to $55 from $50 at Barclays
Barclays analyst Brandon Oglenski raised his price target for CSX to $55 after introducing new estimates to reflect his best estimate of what he thinks new CEO Hunter Harrison can achieve. The analyst notes that his near $4 in earnings per share for 2020 represents a doubling of earnings from current levels. Harrison acted quickly at CP, with most margin improvement realized in less than three years, Oglenski tells investors in a research note. He keeps an Overweight rating on CSX.
ADS Alliance Data
$254.88

14.24 (5.92%)

03/24/17
DBAB
03/24/17
NO CHANGE
Target $278
DBAB
Buy
Alliance Data price target raised to $278 from $263 at Deutsche Bank
Deutsche Bank analyst Ashish Sabadra raised his price target for Alliance Data Systems to $278 saying higher interest rates and the accelerated share repurchase in early 2017 could potentially drive upside to the full year guidance. The analyst ADS to post an in-line quarter and reiterate its outlook for the year. He keeps a Buy rating on the shares.
04/11/17
OPCO
04/11/17
INITIATION
Target $185
OPCO
Underperform
Alliance Data initiated with an Underperform at Oppenheimer
Oppenheimer analyst Ben Chittenden started Alliance Data with an Underperform rating and a $185 price target, noting that profitability is under pressure and earnings will continue to be driven by the card business.
01/26/17
RAJA
01/26/17
DOWNGRADE
RAJA
Market Perform
Alliance Data downgraded to Market Perform from Outperform at Raymond James
12/09/16
JPMS
12/09/16
DOWNGRADE
Target $255
JPMS
Neutral
Alliance Data downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Reginald Smith downgraded Alliance Data to Neutral saying higher funding costs and concerns over a peaking consumer credit cycle will weigh on the shares. The analyst lowered his price target for the stock to $255 from $260.
KEY KeyCorp
$18.01

0.6389 (3.68%)

01/20/17
SDLR
01/20/17
DOWNGRADE
SDLR
Hold
KeyCorp downgraded to Hold from Buy at Sandler O'Neill
03/23/17
DADA
03/23/17
INITIATION
Target $19
DADA
Neutral
KeyCorp initiated with a Neutral at DA Davidson
DA Davidson analyst Kevin Reevey initiated KeyCorp with a Neutral and a $19 price target saying above-peer delinquencies and net charge-offs in its auto loan portfolio could limit near-term multiple expansion.
03/03/17
EVER
03/03/17
UPGRADE
EVER
Outperform
KeyCorp upgraded to Outperform from Hold at Evercore ISI
03/03/17
03/03/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Expedia (EXPE) upgraded to Neutral from Sell at Citi with analyst Mark May citing greater comfort in the growth of the company's hotel business. The analyst, who noted that recently disclosed room night and bookings growth at HomeAway gives him a more bullish view on its long-term growth, raised his price target on Expedia shares to $130 from $116. 2. Helmerich & Payne (HP) upgraded to Outperform from Market Perform at Bernstein with analyst Colin Davies citing higher U.S. rig demand and valuation. Target to $84 from $86. 3. Dr Pepper Snapple (DPS) upgraded to Buy from Hold at Jefferies with analyst Kevin Grundy saying that its recently-acquired Bai brand is an underappreciated growth platform for the company. He expects Bai to contribute 2-3 points to Dr Pepper's core sales growth over the next 3-5 years and increased his 2017-18 organic sales and EPS forecasts. Grundy increased his price target on Dr Pepper shares to $115 from $98. 4. KeyCorp (KEY) upgraded to Outperform from Hold at Evercore ISI. 5. Southern Company (SO) upgraded to Buy from Hold at Jefferies with analyst Anthony Crowdell saying he thinks the company will be able to deliver on its 5% earnings per share growth target given all the levers available to pull. He also believes investors are pricing in a Kemper scenario that is worse than worst-case and sees the Vogtle nuclear project is less of a concern than is factored in at current levels, Crowdell tells investors. He raised his price target on Southern Company shares to $56 from $50. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GPS Gap
$25.26

1.04 (4.29%)

03/08/17
GUGG
03/08/17
INITIATION
GUGG
Neutral
Gap initiated with a Neutral at Guggenheim
01/06/17
BARD
01/06/17
NO CHANGE
Target $26
BARD
Neutral
Gap estimates raised but risk/reward remains balanced, says Baird
Baird analyst Mark Altschwager noted Gap reported better than expected comps buoyed by Old Navy and the company signaled modest upside to guidance. The analyst raised his estimates but said visibility into sustainable sales/margin improvement remains cloudy, yielding a balanced risk/reward at current levels. Altschwager maintained his Neutral rating and $26 price target on Gap shares.
02/07/17
JEFF
02/07/17
NO CHANGE
Target $36
JEFF
Buy
Jefferies calls on Gap to consider alternatives for Banana
While the Gap brand last night reported its second consecutive month of positive comparable sales, and Old Navy remained positive, Banana Republic continued to struggle with comp sales down 4%, Jefferies analyst Randal Konik tells investors in a research note. Management needs to take action, the analyst argues. He believes management should consider strategic alternatives for Banana including a potential sale, massively reducing the store footprint, or shutting down the brand. Konik has a Buy rating on Gap with a $36 price target.
04/20/17
JPMS
04/20/17
UPGRADE
Target $24
JPMS
Neutral
Gap upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Matthew Boss upgraded The Gap to Neutral citing the underperformance of the shares over the past 18 months and his fieldwork which suggests stability at Old Navy. The analyst raised his price target for the shares to $24 from $21.
AXP American Express
$78.20

2.65 (3.51%)

04/20/17
JPMS
04/20/17
NO CHANGE
Target $94
JPMS
Overweight
JPMorgan says American Express 'becoming great again,' ups target to $94
In a research note titled "Becoming Great Again," JPMorgan analyst Richard Shane raised his price target for American Express shares to $94 from $90 following the company's Q1 results. The analyst expects a positive reaction when the market opens. The earnings beat was driven by strong top-line growth while American Express' loan growth continues ahead of the industry, Shane tells investors in a post-earnings research note. He keeps an Overweight rating on the shares.
03/24/17
03/24/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. American Express (AXP) initiated with a Neutral at Tigress Financial. 2. Zosano Pharma (ZSAN) initiated with an Overweight at Piper Jaffray. 3. SkyWest (SKYW) initiated with an In-Line at Imperial Capital. 4. Statoil (STO) initiated with an Underperform at Macquarie. 5. Cogent (CCOI) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/24/17
TIGR
03/24/17
INITIATION
TIGR
Neutral
American Express initiated with a Neutral at Tigress Financial
Tigress Financial analyst Ivan Feinseth initiated American Express with a Neutral saying business performance remains weak due to increasing competition and the loss of its largest customer and views shares as fairly valued.
04/20/17
OPCO
04/20/17
NO CHANGE
Target $93
OPCO
Outperform
American Express fundamentals already shifting more positive, says Oppenheimer
Oppenheimer analyst Ben Chittenden continues to like the American Express story and says the Q1 results only reinforce why he likes it. The analyst believes this is a company where sentiment is very negative yet the fundamentals are already shifting more positive. While competition is clearly more intense post crisis, American Express is managing through it, he adds. Chittenden reiterates an Outperform rating and $93 price target on the shares.

TODAY'S FREE FLY STORIES

EADSY

Airbus

$23.76

-0.135 (-0.56%)

, BDRBF

Bombardier

$2.25

0.04 (1.81%)

12:57
10/22/17
10/22
12:57
10/22/17
12:57
Periodicals
Airbus turmoil overshadows bid to rescue Bombardier CSeries, Reuters says »

Airbus's (EADSY)…

EADSY

Airbus

$23.76

-0.135 (-0.56%)

BDRBF

Bombardier

$2.25

0.04 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$257.11

1.32 (0.52%)

, SPX

S&P 500

11:19
10/22/17
10/22
11:19
10/22/17
11:19
Periodicals
Senate Republican Leader says tax bill to be revenue neutral, Reuters reports »

Mitch McConnell said he…

SPY

SPDR S&P 500 ETF Trust

$257.11

1.32 (0.52%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$15.56

0.31 (2.03%)

11:15
10/22/17
10/22
11:15
10/22/17
11:15
Periodicals
People use Snapchat at parties, not as much at sports stadiums, Recode says »

There seems to be a huge…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

  • 08

    Nov

  • 15

    Nov

TSLA

Tesla

$345.10

-6.71 (-1.91%)

11:09
10/22/17
10/22
11:09
10/22/17
11:09
Periodicals
Tesla reaches deal for Shanghai manufacturing facility, WSJ reports »

Tesla has reached an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

, UNH

UnitedHealth

$207.49

4.24 (2.09%)

11:01
10/22/17
10/22
11:01
10/22/17
11:01
Periodicals
Senator McConnell waiting for Trump's OK on healthcare bill, Reuters says »

Republican Senate Leader…

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

CNC

Centene

$96.50

1.8 (1.90%)

WCG

WellCare

$180.52

3.28 (1.85%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

AET

Aetna

$160.84

3.2 (2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

TSLA

Tesla

$345.10

-6.71 (-1.91%)

10:57
10/22/17
10/22
10:57
10/22/17
10:57
Periodicals
Tesla expects to agree on deal to build cars in China by year-end, Reuters says »

Tesla is talking with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.90

0.12 (0.20%)

, DAL

Delta Air Lines

$53.27

1 (1.91%)

09:51
10/21/17
10/21
09:51
10/21/17
09:51
Periodicals
Market pounds United, sees American/Delta as possibly safe bets, Barron's says »

United Continental's…

UAL

United Continental

$59.90

0.12 (0.20%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

CZR

Caesars

$12.20

0.15 (1.24%)

09:45
10/21/17
10/21
09:45
10/21/17
09:45
Periodicals
Caesars looks ready to grow again, Barron's says »

After a disastrous 2008…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

DWDP

DowDuPont

$71.18

0.29 (0.41%)

09:40
10/21/17
10/21
09:40
10/21/17
09:40
Periodicals
DowDuPont shares likely to return as much as 30% over next year, Barron's says »

If DowDuPont can cut $3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

0.88 (2.23%)

09:29
10/21/17
10/21
09:29
10/21/17
09:29
Periodicals
Coach shares look undervalued, could rise nearly 30%, Barron's says »

Coach, which has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$96.50

1.8 (1.90%)

, MOH

Molina Healthcare

$64.40

0.76 (1.19%)

09:24
10/21/17
10/21
09:24
10/21/17
09:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$96.50

1.8 (1.90%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

AET

Aetna

$160.84

3.2 (2.03%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

CYH

Community Health

$6.44

0.24 (3.87%)

HCA

HCA Healthcare

$81.05

1.26 (1.58%)

LPNT

LifePoint

$58.35

0.5 (0.86%)

THC

Tenet

$14.66

1.31 (9.81%)

UHS

Universal Health

$112.85

2.31 (2.09%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

FB

Facebook

$174.98

0.42 (0.24%)

INTC

Intel

$40.43

0.34 (0.85%)

IBM

IBM

$162.07

1.17 (0.73%)

MAR

Marriott

$115.02

-0.18 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 29

    Nov

  • 30

    Nov

  • 18

    Mar

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

08:55
10/21/17
10/21
08:55
10/21/17
08:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

08:45
10/21/17
10/21
08:45
10/21/17
08:45
General news
Breaking General news story  »

New York Federal Reserve…

FB

Facebook

$174.98

0.42 (0.24%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

08:25
10/21/17
10/21
08:25
10/21/17
08:25
Periodicals
Regulators inquiries fuel speculation about big tech breakup, Barron's says »

Facebook (FB), Amazon…

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

07:58
10/21/17
10/21
07:58
10/21/17
07:58
Hot Stocks
DBV believes FDA suggested continue moving forward with Viaskin »

DBV Technologies (DBVT)…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

04:55
10/21/17
10/21
04:55
10/21/17
04:55
General news
Breaking General news story  »

New York Federal Reserve…

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

04:55
10/21/17
10/21
04:55
10/21/17
04:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.